blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3099293

EP3099293 - NANOENCAPSULATION OF HYDROPHILIC ACTIVE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.09.2021
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  16.10.2020
FormerGrant of patent is intended
Status updated on  25.09.2020
FormerExamination is in progress
Status updated on  18.08.2020
FormerGrant of patent is intended
Status updated on  23.04.2020
FormerExamination is in progress
Status updated on  19.10.2018
FormerRequest for examination was made
Status updated on  04.11.2016
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Hi-Tech Park
Edmond J. Safra Campus
Givat Ram
91390 Jerusalem / IL
[2016/49]
Inventor(s)01 / BENITA, Simon
3 Adam Hacohen Street
6458509 Tel Aviv / IL
02 / NASSAR, Taher
Anwar Street
P.O. Box 2646
1695000 Kfar Tur'an / IL
03 / KOCHAVI-SOUDRY, Liat
10 Dekel Street, App.5
P.O.B 6043
6082262 Shoham / IL
 [2016/49]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/49]
Application number, filing date15706540.026.01.2015
[2016/49]
WO2015IL50091
Priority number, dateUS201461931910P27.01.2014         Original published format: US 201461931910 P
US201462080607P17.11.2014         Original published format: US 201462080607 P
[2016/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015111062
Date:30.07.2015
Language:EN
[2015/30]
Type: A1 Application with search report 
No.:EP3099293
Date:07.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 30.07.2015 takes the place of the publication of the European patent application.
[2016/49]
Type: B1 Patent specification 
No.:EP3099293
Date:18.11.2020
Language:EN
[2020/47]
Search report(s)International search report - published on:EP30.07.2015
ClassificationIPC:A61K9/14, A61K9/51
[2016/49]
CPC:
A61K9/5161 (EP,CN,KR,US); A61K9/5169 (EP,CN,KR,US); A61K31/404 (EP,US);
A61K38/2278 (EP,US); A61K38/25 (EP,KR,US); A61K38/26 (EP,CN,KR,US);
A61K38/28 (EP,CN,KR,US); A61K38/385 (EP,KR,US); A61K47/593 (EP,US);
A61K47/60 (EP,US); A61K47/6937 (EP,US); A61K9/0053 (EP,KR,US);
A61K9/146 (EP,KR,US); A61K9/1635 (EP,KR,US); A61K9/1652 (EP,KR,US);
A61K9/5153 (EP,CN,KR,US); A61K9/5192 (CN,US); A61P3/10 (EP);
Y10S977/773 (EP,US); Y10S977/906 (EP,US) (-)
C-Set:
A61K38/25, A61K2300/00 (US,EP);
A61K38/26, A61K2300/00 (US,EP);
A61K38/28, A61K2300/00 (US,EP);
A61K38/385, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NANOVERKAPSELUNG VON HYDROPHILEN WIRKSTOFFEN[2016/49]
English:NANOENCAPSULATION OF HYDROPHILIC ACTIVE COMPOUNDS[2016/49]
French:NANOENCAPSULATION DE COMPOSÉS HYDROPHILES ACTIFS[2016/49]
Entry into regional phase27.08.2016National basic fee paid 
27.08.2016Designation fee(s) paid 
27.08.2016Examination fee paid 
Examination procedure25.08.2016Amendment by applicant (claims and/or description)
25.08.2016Date on which the examining division has become responsible
27.08.2016Examination requested  [2016/49]
19.10.2018Despatch of a communication from the examining division (Time limit: M04)
07.02.2019Reply to a communication from the examining division
24.04.2020Communication of intention to grant the patent
18.08.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.08.2020Fee for grant paid
18.08.2020Fee for publishing/printing paid
02.10.2020Communication of intention to grant the patent
12.10.2020Receipt of the translation of the claim(s)
Opposition(s)19.08.2021No opposition filed within time limit [2021/43]
Fees paidRenewal fee
25.01.2017Renewal fee patent year 03
15.01.2018Renewal fee patent year 04
15.01.2019Renewal fee patent year 05
14.01.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.01.2015
AL18.11.2020
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
MK18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
BE31.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
[2024/22]
Former [2023/30]HU26.01.2015
AL18.11.2020
AT18.11.2020
CY18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
BE31.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2023/27]HU26.01.2015
AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
BE31.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2022/34]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
BE31.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2022/23]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2022/10]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
NO18.02.2021
GR19.02.2021
PT18.03.2021
Former [2022/07]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
IE26.01.2021
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/50]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SI18.11.2020
SK18.11.2020
SM18.11.2020
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/46]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
NL18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/45]AL18.11.2020
AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/43]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
LU26.01.2021
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/40]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
MC18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/37]AT18.11.2020
CZ18.11.2020
DK18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/36]AT18.11.2020
CZ18.11.2020
EE18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/35]AT18.11.2020
CZ18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
RO18.11.2020
RS18.11.2020
SK18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/34]AT18.11.2020
CZ18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
RS18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/33]AT18.11.2020
FI18.11.2020
HR18.11.2020
LT18.11.2020
LV18.11.2020
RS18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/32]AT18.11.2020
FI18.11.2020
HR18.11.2020
LV18.11.2020
RS18.11.2020
SM18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/28]AT18.11.2020
FI18.11.2020
HR18.11.2020
LV18.11.2020
RS18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/25]AT18.11.2020
FI18.11.2020
LV18.11.2020
RS18.11.2020
NO18.02.2021
GR19.02.2021
IS18.03.2021
PT18.03.2021
Former [2021/23]AT18.11.2020
FI18.11.2020
LV18.11.2020
RS18.11.2020
NO18.02.2021
GR19.02.2021
PT18.03.2021
Former [2021/22]FI18.11.2020
RS18.11.2020
NO18.02.2021
PT18.03.2021
Former [2021/21]FI18.11.2020
PT18.03.2021
Former [2021/20]FI18.11.2020
Cited inInternational search[XI]ES2382625  (UNIV SANTIAGO COMPOSTELA [ES], et al) [X] 1,4-7,9,10,13-15,20-23,29,30 * page 5, line 47 - page 10, line 35 * * figure 3; example 3 * * claims 1, 7-15, 19-23 * [I] 1-31;
 [XI]  - GIOVANNI KONAT ZORZI ET AL, "Hybrid Nanoparticle Design Based on Cationized Gelatin and the Polyanions Dextran Sulfate and Chondroitin Sulfate for Ocular Gene Therapy", MACROMOLECULAR BIOSCIENCE, (20110707), vol. 11, no. 7, doi:10.1002/mabi.201100005, ISSN 1616-5187, pages 905 - 913, XP055185376 [X] 1,4-7,9,10,13-15,20-23,29,30 * abstract * * page 905 - page 909 * * page 912 * * tables 3-5 * [I] 1-31

DOI:   http://dx.doi.org/10.1002/mabi.201100005
 [A]  - WOITISKI C B ET AL, "Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 73, no. 1, doi:10.1016/J.EJPB.2009.06.002, ISSN 0939-6411, (20090901), pages 25 - 33, (20090607), XP026467626 [A] 1-31 * abstract * * 1. Introduction 2.2.1. Preparation of nanoparticles 4. Conclusions *

DOI:   http://dx.doi.org/10.1016/j.ejpb.2009.06.002
by applicantWO2012101639
    - TSUJI, K.; TSUTANI, K., EUR. J. PHARM. BIOPHARM., (2008), vol. 68, pages 496 - 502
    - JOSHI, M.D.; MULLER, R.H., EUR. J. PHARM. BIOPHARML.,, (2009), vol. 71, pages 161 - 172
    - KLUGE, J.; FUSARO, F.; MUHRER, G.; THAKUR, R.; MAZZOTTI, M., J. SUPERCRIT. FLUIDS, (2009), vol. 48, pages 176 - 182
    - MEHNERT, W.; MADER, K., ADV. DRUG DELIV. REV.,, (2001), vol. 47, pages 165 - 196
    - GURSOY RN; BENITA S., BIOMED PHARMACOTHER., (2004), vol. 58, pages 173 - 82
    - ALMEIDA, A.J.; SOUTO, E., ADV.DRUG DELIV. REV., (2007), vol. 59, pages 478 - 490
    - BILATI, U.; ALLÉMANN, E.; DOELKER, E., EUR. J. PHARM. BIOPHARM., (2005), vol. 59, pages 375 - 388
    - MUNDARGI, R.C.; BABU, V.R.; RANGASWAMY, V.; PATEL, P.; AMINABHAVI, T.M., J. CONTROL. RELEASE, (2008), vol. 125, pages 193 - 209
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.